{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:21:39Z","timestamp":1772194899499,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1124\/dmd.104.002782","type":"journal-article","created":{"date-parts":[[2005,1,8]],"date-time":"2005-01-08T01:47:57Z","timestamp":1105148877000},"page":"596-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME"],"prefix":"10.1016","volume":"33","author":[{"given":"Norito","family":"Takamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuo","family":"Chosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Uryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Otagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.104.002782_bib1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1681\/ASN.V1161100","article-title":"Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.","volume":"11","author":"Agarwal","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/dmd.104.002782_bib2","first-page":"16","article-title":"Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.","volume":"46","author":"Bertani","year":"1982","journal-title":"Lab Investig"},{"key":"10.1124\/dmd.104.002782_bib3","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1248\/cpb.33.3415","article-title":"Study of interactions between ibuprofen and sulfonamides and between bucolome and sulfonamides in rats.","volume":"33","author":"Chiba","year":"1985","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/dmd.104.002782_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0024-3205(80)90238-6","article-title":"Resistance of proteinuric rats to furosemide: urinary drug protein binding as a determinant of drug effect.","volume":"26","author":"Green","year":"1980","journal-title":"Life Sci"},{"key":"10.1124\/dmd.104.002782_bib5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1248\/cpb.18.2386","article-title":"Effect of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine on the sulfonamides transfer in the rat.","volume":"18","author":"Kakemi","year":"1970","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/dmd.104.002782_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/clpt.1982.187","article-title":"Disposition and diuretic effect of furosemide in the nephrotic syndrome.","volume":"32","author":"Keller","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.104.002782_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0022-3565(25)20166-5","article-title":"Intratubular albumin blunts the response to furosemide\u2014a mechanism for diuretic resistance in the nephrotic syndrome.","volume":"252","author":"Kirchner","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.104.002782_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.1991.228","article-title":"Binding inhibitors restore furosemide potency in tubule fluid containing albumin.","volume":"40","author":"Kirchner","year":"1991","journal-title":"Kidney Int"},{"key":"10.1124\/dmd.104.002782_bib9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1681\/ASN.V271201","article-title":"Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats.","volume":"2","author":"Kirchner","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/dmd.104.002782_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0031-6997(25)06849-8","article-title":"Molecular aspects of ligand binding to serum albumin.","volume":"33","author":"Kragh-Hansen","year":"1981","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.104.002782_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.104.002782_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","article-title":"Mechanism of impaired natriuretic response to furosemide during prolonged therapy.","volume":"36","author":"Loon","year":"1989","journal-title":"Kidney Int"},{"key":"10.1124\/dmd.104.002782_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0026-895X(25)14586-0","article-title":"Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.","volume":"21","author":"Maes","year":"1982","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.104.002782_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/207274a0","article-title":"Potential effect of the plasma on drug distribution.","volume":"207","author":"Martin","year":"1965","journal-title":"Nature (Lond)"},{"key":"10.1124\/dmd.104.002782_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.2042-7158.1986.tb03102.x","article-title":"On the modulating effects of temperature, albumin, pH and calcium on the free fractions of phenobarbitone and phenytoin.","volume":"38","author":"Melten","year":"1986","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.104.002782_bib16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jps.2600570601","article-title":"The binding of drugs by plasma proteins.","volume":"57","author":"Meyer","year":"1968","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.104.002782_bib17","first-page":"327","article-title":"[A case of heterozygous protein C deficiency associated with nephrotic syndrome and deep femoral artery thrombosis].","volume":"33","author":"Sato","year":"1991","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"10.1124\/dmd.104.002782_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jps.2600740604","article-title":"Urinary protein binding, kinetics and dynamics of furosemide in nephrotic patients.","volume":"74","author":"Smith","year":"1985","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.104.002782_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1016098305796","article-title":"Mode of interaction of loop diuretics with human serum albumin and characterization of binding site.","volume":"13","author":"Takamura","year":"1996","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.104.002782_bib20","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/clinchem\/43.12.2274","article-title":"Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia.","volume":"43","author":"Takamura","year":"1997","journal-title":"Clin Chem"},{"key":"10.1124\/dmd.104.002782_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1248\/bpb.21.174","article-title":"Effects of fatty acids on serum binding between furosemide and valproic acid.","volume":"21","author":"Takamura","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.104.002782_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2131\/jts.3.1","article-title":"Influence of some anti-inflammatory, antipyretic and analgesic agents on urinary enzyme level in rats.","volume":"3","author":"Tsurumi","year":"1978","journal-title":"J Toxicol Sci"},{"key":"10.1124\/dmd.104.002782_bib23","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1023\/A:1018842506896","article-title":"Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin.","volume":"16","author":"Tsutsumi","year":"1999","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.104.002782_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jps.2600660402","article-title":"Binding of drugs by albumin and plasma protein.","volume":"66","author":"Vallner","year":"1977","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.104.002782_bib25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1681\/ASN.V133798","article-title":"New insights into diuretic use in patients with chronic renal disease.","volume":"13","author":"Wilcox","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/dmd.104.002782_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (MULTI) for microcomputer.","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J Pharmacobio-Dyn"},{"key":"10.1124\/dmd.104.002782_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1248\/cpb.19.881","article-title":"Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. V. Pharmacokinetics of BCP in man and in rabbit following intravenous administration of BCPNa.","volume":"19","author":"Yashiki","year":"1971","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/dmd.104.002782_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1248\/cpb.19.869","article-title":"Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. IV. Pharmacokinetics of BCP in man following oral administration.","volume":"19","author":"Yashiki","year":"1971","journal-title":"Chem Pharm Bull (Tokyo)"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624031544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624031544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.104.002782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:10:14Z","timestamp":1739898614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624031544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0090955624031544"],"URL":"https:\/\/doi.org\/10.1124\/dmd.104.002782","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.104.002782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}